Cargando…

Serum Free Fatty Acids Independently Predict Adverse Outcomes in Acute Heart Failure Patients

Background: Perturbation of energy metabolism exacerbates cardiac dysfunction, serving as a potential therapeutic target in congestive heart failure. Although circulating free fatty acids (FFAs) are linked to insulin resistance and risk of coronary heart disease, it still remains unclear whether cir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yi, Jin, Chunna, Zhao, Chengchen, Zhu, Shiyu, Meng, Simin, Ma, Hong, Wang, Jian'an, Xiang, Meixiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727366/ https://www.ncbi.nlm.nih.gov/pubmed/35004879 http://dx.doi.org/10.3389/fcvm.2021.761537

Ejemplares similares

Loss of perceived social role, an index of social frailty, is an independent predictor of future adverse events in hospitalized patients with heart failure
por: Watanabe, Ayako, et al.
Publicado: (2022)

Increased serum methylmalonic acid levels were associated with the presence of cardiovascular diseases
por: Wang, Xiaoya, et al.
Publicado: (2022)

Correlations between serum laminin level and severity of heart failure in patients with chronic heart failure
por: Xie, Ling, et al.
Publicado: (2023)

Fragmented QRS Is Independently Predictive of Long-Term Adverse Clinical Outcomes in Asian Patients Hospitalized for Heart Failure: A Retrospective Cohort Study
por: Chan, Jeffrey Shi Kai, et al.
Publicado: (2021)

Short-Chain Fatty Acids in the Metabolism of Heart Failure – Rethinking the Fat Stigma
por: Palm, Constantin L., et al.
Publicado: (2022)

Increased Serum Soluble Transferrin Receptor Levels Were Associated With High Prevalence of Cardiovascular Diseases: Insights From the National Health and Nutrition Examination Survey 2017–2018
por: Zhu, Shiyu, et al.
Publicado: (2022)

Effects of treatment of non-alcoholic fatty liver disease on heart failure with preserved ejection fraction
por: Yang, Zifeng, et al.
Publicado: (2023)

MELD-XI Score Is Associated With Short-Term Adverse Events in Patients With Heart Failure With Preserved Ejection
por: Wang, Sunying, et al.
Publicado: (2021)

Renal Venous Stasis Index Reflects Renal Congestion and Predicts Adverse Outcomes in Patients With Heart Failure
por: Ohara, Himika, et al.
Publicado: (2022)

Prognostic Value of Serum Galectin-3 in Chronic Heart Failure: A Meta-Analysis
por: Cheng, Zhendong, et al.
Publicado: (2022)

Intestinal fatty acid binding protein is associated with cardiac function and gut dysbiosis in chronic heart failure
por: Nendl, Andraž, et al.
Publicado: (2023)

Cardio-Ankle Vascular Index Reflects Impaired Exercise Capacity and Predicts Adverse Prognosis in Patients With Heart Failure
por: Watanabe, Koichiro, et al.
Publicado: (2021)

Corrigendum: MELD-XI Score Is Associated With Short-Term Adverse Events in Patients With Heart Failure With Preserved Ejection
por: Wang, Sunying, et al.
Publicado: (2021)

Uric Acid Predicts Recovery of Left Ventricular Function and Adverse Events in Heart Failure With Reduced Ejection Fraction: Potential Mechanistic Insight From Network Analyses
por: Wang, Xiqiang, et al.
Publicado: (2022)

Quality improvement strategies to optimise transition of patients with heart failure to independent living: protocol for a scoping review
por: Kastner, Monika, et al.
Publicado: (2014)

Correlation of left atrial function and pulmonary edema in patients with left heart failure on cardiopulmonary ultrasonography
por: Li, Hong, et al.
Publicado: (2023)

Diagnostic Value of Serum Concentration of Galectin-3 in Patients With Heart Failure With Preserved Ejection Fraction
por: Jiang, Jing, et al.
Publicado: (2022)

Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
por: Wang, Zeyu, et al.
Publicado: (2022)

Resting Cardiac Power Predicts Adverse Outcome in Heart Failure Patients With Preserved Ejection Fraction: A Prospective Study
por: Wang, Shiqi, et al.
Publicado: (2022)

A prediction model for major adverse cardiovascular events in patients with heart failure based on high-throughput echocardiographic data
por: Sun, Qinliang, et al.
Publicado: (2022)

U-Shaped Association Between Serum Uric Acid Level and Hypertensive Heart Failure: A Genetic Matching Case-Control Study
por: Xu, Hongxuan, et al.
Publicado: (2021)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

GENERATOR HEART FAILURE DataMart: An integrated framework for heart failure research
por: D’Amario, Domenico, et al.
Publicado: (2023)

Ca(2+)/Calmodulin-Dependent Protein Kinase II Regulation by RIPK3 Alleviates Necroptosis in Transverse Arch Constriction-Induced Heart Failure
por: Cao, Ji, et al.
Publicado: (2022)

Association Between Prognostic Nutritional Index and Prognosis in Patients With Heart Failure: A Meta-Analysis
por: Chen, Mei-Yu, et al.
Publicado: (2022)

Alterations of Gut Microbiome and Serum Metabolome in Coronary Artery Disease Patients Complicated With Non-alcoholic Fatty Liver Disease Are Associated With Adverse Cardiovascular Outcomes
por: Hu, Xiaomin, et al.
Publicado: (2022)

Restructuring the Heart From Failure to Success: Role of Structural Interventions in the Realm of Heart Failure
por: Kir, Devika, et al.
Publicado: (2022)

β-sheets in serum protein are independent risk factors for coronary lesions besides LDL-C in coronary heart disease patients
por: Li, Yu-lin, et al.
Publicado: (2022)

Lower Plasma Elabela Levels in Hypertensive Patients With Heart Failure Predict the Occurrence of Major Adverse Cardiac Events: A Preliminary Study
por: Ma, Zheng, et al.
Publicado: (2021)

Qili Qiangxin capsules for chronic heart failure: A GRADE-assessed clinical evidence and preclinical mechanism
por: Xing, Xiaoxiao, et al.
Publicado: (2023)

Using a Two-Sample Mendelian Randomization Method in Assessing the Causal Relationships Between Human Blood Metabolites and Heart Failure
por: Wang, Zixian, et al.
Publicado: (2021)

Epi-Drugs in Heart Failure
por: Gorica, Era, et al.
Publicado: (2022)

Circulating sphingolipids in heart failure
por: Kovilakath, Anna, et al.
Publicado: (2023)

Inflammation in acute heart failure
por: Garofalo, Manuel, et al.
Publicado: (2023)

Is Heart Failure a New Risk Factor for Incident Cancer?
por: Zheng, Xueyang, et al.
Publicado: (2022)

The feasibility and safety of his-purkinje conduction system pacing in patients with heart failure with severely reduced ejection fraction
por: Ma, Chengming, et al.
Publicado: (2023)

Mending a broken heart—targeting cardiomyocyte regeneration: a literature review
por: Jin, Chunna, et al.
Publicado: (2022)

Comparative Efficacy of Medical Treatments for Chronic Heart Failure: A Network Meta-Analysis
por: Xiang, Boyang, et al.
Publicado: (2022)

Unmet Needs in Patients With Heart Failure: The Importance of Palliative Care in a Heart Failure Clinic
por: Gonzalez-Jaramillo, Valentina, et al.
Publicado: (2022)

Heart failure with preserved ejection fraction: Calculating the risk of future heart failure events and death
por: Schrutka, Lore, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i35mmj83p9rvttoflad1lnc5rt